Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2
Release Date: 05/12/2025
Neurology Minute
In part one of this two-part series, Dr. Halley Alexander and Dr. Coral M. Stredny discuss the importance of seizure action plans and how this might translate into our clinical care. Show reference:
info_outlineNeurology Minute
Dr. Nadia Khalil and Dr. Jean Bouchart discuss the diagnostic approach to intracerebral hemorrhage, the causes of cerebral small vessel disease, and the interpretation of biomolecular tests. Show reference:
info_outlineNeurology Minute
In the final episode of this three-part series, Dr. Jodie Roberts and Dr. Urs Fisch discuss functional/dissociative seizures and driving risk. Learn more about the section and fill out the current survey on .
info_outlineNeurology Minute
In part two of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss how often seizure-like or seizure-resembling episodes lead to a diagnosis of functional neurologic disorder. Learn more about the section and fill out the current survey on .
info_outlineNeurology Minute
In part one of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss the term "functional seizures" and clarify the terminology. Learn more about the section and fill out the current survey on .
info_outlineNeurology Minute
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss small vessel primary CNS vasculitis. Show reference:
info_outlineNeurology Minute
Dr. Greg Cooper and Dr. David A. Wolk discuss limbic predominant age-related TDP-43 encephalopathy (LATE), covering its clinical features, diagnostic criteria, and more. Show reference:
info_outlineNeurology Minute
In the second installment of this three-part series, Dr. Elizabeth Zollos discusses the use of magnetic resonance imaging (MRI) in multiple sclerosis diagnosis.
info_outlineNeurology Minute
In the first episode of the AAN President's Spotlight series, Dr. Jason Crowell speaks with the new AAN President, Dr. Natalia S. Rost, as she outlines her vision and key priorities for her two-year term. Show references:
info_outlineNeurology Minute
In part two of this two-part series, Dr. Stacey Clardy and Dr. Elia Sechi discuss how to approach the management of patients in clinic when there is concern for a possible false positive on the radioimmunoprecipitation assay for the acetylcholine receptor antibody. Show reference:
info_outlineIn part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.